Labcorp (NYSE:LH – Get Free Report) had its price objective hoisted by investment analysts at JPMorgan Chase & Co. from $330.00 to $360.00 in a research note issued to investors on Monday,Benzinga reports. JPMorgan Chase & Co.‘s price objective points to a potential upside of 16.23% from the company’s current price. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $306.00 target price on shares of Labcorp in a research report on Friday. Truist Financial upped their price target on Labcorp from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Friday. Labcorp Company Profile(Get Free Report)Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services.